Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target vol...
Main Authors: | K. M. Kraus, M. Oechsner, J. J. Wilkens, K. A. Kessel, S. Münch, S. E. Combs |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-85031-w |
Similar Items
-
Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)
by: Kerstin A. Kessel, et al.
Published: (2020-05-01) -
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
by: Theresa Voglhuber, et al.
Published: (2020-06-01) -
Dosimetric comparison of different algorithms in stereotactic body radiation therapy (SBRT) plan for non-small cell lung cancer (NSCLC)
by: Zhang J, et al.
Published: (2019-08-01) -
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
by: Christian D. Diehl, et al.
Published: (2019-11-01) -
Surgical Resection Versus Stereotactic Body Radiation Therapy for Stage I NSCLC: Can Randomized Trials Provide the Solution?
by: Melanie P. Subramanian, et al.
Published: (2018-09-01)